Пресс-релизы

Brainlab Multiple Metastases Planning and Other Revolutionary Software Applications Now Available in the United States

Multiple Metastases Planning and Adaptive Hybrid Surgery, part of the Brainlab Elements portfolio, receive FDA clearance

Chicago, 19 декабря 2014 г.

Brainlab, a global developer of software-driven medical technology, announced today 510(k) clearance for two software modules for radiation oncologists and neurosurgeons. Adaptive Hybrid Surgery and Automatic Brain Metastases Planning software by Brainlab round out the Brainlab portfolio and build on the company’s mission to increase access to and consistency of patient care. These intelligent shaping tools are now available in the United States after successful clinical use in several international markets.

Adaptive Hybrid Surgery by Brainlab helps physicians to balance surgical risk with radiosurgical toxicity for multi-disciplinary treatment of skull-base tumors. A complete set of automated tools enables analysis of adjuvant radiosurgery at any time, while planning and performing a surgical resection. Elements Intraoperative Structure Update captures residual tumor volumes based on points acquired inside the resection cavity. An intuitive traffic light display provides comprehensive information about tumor coverage and critical dose constraints for calculated treatment plans.

Automatic Brain Metastasis Planning software by Brainlab introduces the market to technology that consistently and rapidly generates radiosurgery plans for the efficient treatment of multiple metastases. This breakthrough technology allows clinicians to plan and treat multiple brain metastases with time and dose efficiencies while helping to minimize exposure to healthy surrounding tissue. Treatment delivery and planning time can be reduced drastically, even for as many as 10 metastatic tumors in the brain.
“FDA clearance of these software modules marks a critical milestone in the Brainlab vision of indication-specific tools,” said Stefan Vilsmeier, President and CEO of Brainlab. “We expect their capabilities, efficiency and usability to help change the way certain life-threatening diseases are treated.”

Brainlab AG

Brainlab creates software-driven med tech digitizing, automating and optimizing clinical workflows. Serving physicians, medical professionals and patients in 6700 hospitals in 127 countries, we’re transforming healthcare to improve the lives of patients everywhere. We employ over 2400 people in 25 locations worldwide. Visit and follow: Brainlab, LinkedIn, Twitter, Facebook and Instagram.